Nauka i natura

MedChemExpress

Ripretinib (DCC-2618) is an orally bioavailable, selective KIT and PDGFRA switch-control inhibitor. Ripretinib (DCC-2618) targets and binds to both wild-type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. Ripretinib (DCC-2618) also inhibits multiple other kinase targets, such as FLT3 and KDR (or VEGFR-2). DCC-2618 exerts antineoplastic effect and induces apoptosis.
More details:https://www.medchemexpress.com/DCC-2618.html
Dodał Hubert Rodriguez
biochemical

Podobne inspiracje

Lubię to Komentuj
MK-4101 is a potent SMO Inhibitor of the Hedgehog Pathw…
life science
Lubię to Komentuj
BAY-876 is a selective GLUT1 inhibitor with an IC50 of…
life science
Lubię to Komentuj
EAI045 is an allosteric inhibitor of mutant EGFR with I…
biochemicals
Lubię to Komentuj
Y-27632 is an ATP-competitive inhibitor of ROCK-I and R…
biochemicals
Lubię to Komentuj
IPI549 is a potent and selective PI3Kγ inhibitor with a…
biochemicals
Lubię to Komentuj
Rigosertib (ON-01910) is a multi-kinase inhibitor and a…
biochemical
Lubię to Komentuj
Telcagepant (MK-0974) is a calcitonin gene-related pept…
biochemical
Lubię to Komentuj
Acolbifene (EM-652; SCH 57068) is a fourth-generation s…
Lubię to Komentuj
Tapinarof (Benvitimod; WBI 1001; GSK2894512) is a natur…
Lubię to Komentuj
Gepotidacin (GSK2140944) is a novel triazaacenaphthylen…
Lubię to Komentuj
Desidustat is an inhibitor of HIF hydroxylase extracted…
Lubię to Komentuj
Gefapixant is an orally active P2X3 receptor (P2X3R) an…
Lubię to Komentuj
Rimeporide (EMD-87580) is a potent and selective inhibi…
Lubię to Komentuj
Linerixibat (GSK2330672) is a highly potent, nonabsorba…
MedChemExpress
Momencik, trwa przetwarzanie danych   loading-animation